$NVCR 8-K SEC Filings

Filed On	Filing
01 Oct 2026	8-K: Regulation FD Disclosure Baar, Switzerland – October 1, 2026 – Novocure (Nasdaq: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Optune Pax® for the treatment of adult patients diagnosed with unresectable locally advance...
09 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
01 Sep 2026	8-K: Other Events
23 Jul 2026	8-K: Results of Operations and Financial Condition
30 Jun 2026	8-K: Regulation FD Disclosure
18 Jun 2026	8-K: Regulation FD Disclosure
05 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
30 Apr 2026	8-K: Results of Operations and Financial Condition
09 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
26 Mar 2026	8-K: Regulation FD Disclosure
26 Feb 2026	8-K: Results of Operations and Financial Condition
24 Feb 2026	8-K: Regulation FD Disclosure
11 Feb 2026	8-K: Regulation FD Disclosure
05 Feb 2026	8-K: Regulation FD Disclosure
12 Jan 2026	8-K: Results of Operations and Financial Condition
01 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
30 Oct 2025	8-K: Results of Operations and Financial Condition
15 Sep 2025	8-K: Regulation FD Disclosure
28 Aug 2025	8-K: Regulation FD Disclosure
24 Jul 2025	8-K: Results of Operations and Financial Condition

Comments